Stull said that a number of prescription treatments exist for topical psoriasis, such as steroids and injectable therapies, ...

Risk for the autoimmune hair disorder was reduced by nearly 75% in patients on these treatments for psoriasis, finds a ...

Roflumilast foam, 0.3%, proved to be a simplified treatment regimen with high efficacy for patients with scalp and body ...

The primary endpoint was met, with 57% of subjects treated with the therapy achieving clear or almost clear skin.

Improvements with GLP-1 RAs in psoriasis and other chronic skin diseases point to their increased use in dermatology and a ...

Turmeric, a common spice, has been used in Eastern medicine for centuries. Studies are now examining the benefits of yellow ...

The U.K.’s Medicines and Healthcare products Regulatory Agency has approved guselkumab, or Tremfya, to treat Crohn’s disease ...

Icotrokinra demonstrated high rates of clearance in scalp and genital psoriasis after 16 weeks of treatment, according to ...

What is Trichodynia? Trichodynia, often called scalp dysesthesia, is a condition marked by discomfort or pain in the scalp. At first, it was thought to be caused by hair loss activity or inflammation ...

Researchers have found that Sotyktu, which inhibits the protein TYK2, protects insulin-producing beta cells and, at the same ...

Johnson & Johnson (J&J) and Protagonist Therapeutics’ investigational oral peptide icotrokinra (JNJ-2113) has been associated ...

Using Mind.Px™ test results, altered physician prescribing behavior leads to faster, more effective patient outcomes Mind.Px ...